Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas

Clinical trial NCT02763254 · TERMINATED

Trial details

NCT number: NCT02763254
Sponsor: Cell Medica Ltd
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma Lymphoma, Large B-Cell, Diffuse Post-transplant Lymphoproliferative Disorder

Start date: 2016-11-01
Primary completion: 2018-02-17
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.